IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#909
Positioning
Market Dominance
Manufacturing
Medical Equipment
$141.3B
Kevin A. Lobo
Stryker Corporation operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Medsurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products. The Orthopsurgery segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries.
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Dates updated upon official exchange announcement.
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
X-AXIS: EV/EBITDA (LOWER = CHEAPER) | Y-AXIS: ROE (HIGHER = ELITE) | RED CIRCLE = SYK ANALYSIS TARGET
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$UL UNILEVER PLC | 78 | 96 | 98 | 59 | - | - | 28.5% | 8.0% | 100.0% | 100.0% | 10.4% | -4.6% | 3.3% | 0.0x | $141.8B | VS | |
$ASML ASML HOLDING NV | 77 | 89 | 86 | 83 | - | - | 46.1% | 16.6% | 51.3% | 31.9% | 26.8% | -4.0% | 1.0% | 25.0x | $272.1B | VS | |
$ESLT ELBIT SYSTEMS LTD | 76 | 81 | 87 | 85 | - | - | 10.3% | 3.1% | 24.1% | 7.2% | 4.7% | 14.3% | 0.8% | 25.0x | $11.4B | VS | |
$MT ArcelorMittal | 75 | 71 | 98 | 85 | - | - | 2.2% | 1.5% | 9.3% | 5.3% | 2.2% | -8.5% | 2.2% | 16.0x | $18.9B | VS | |
$AMAT APPLIED MATERIALS INC /DE | 75 | 85 | 87 | 84 | 20.9x | 13.6x | 35.5% | 19.8% | 48.7% | 29.2% | 24.7% | 4.4% | 0.8% | 32.0x | $181.9B | VS | |
$SIMO Silicon Motion Technology CORP | 75 | 84 | 86 | 85 | - | - | 11.8% | 8.8% | 45.9% | 11.3% | 11.1% | 25.7% | 3.7% | 0.0x | $1.8B | VS | |
$CODA Coda Octopus Group, Inc. | 74 | 83 | 90 | 79 | 16.3x | 11.9x | 7.6% | 7.0% | 66.5% | 17.1% | 15.6% | 39.0% | 0.0% | 0.0x | $115M | VS | |
$GSK GSK plc | 74 | 84 | 90 | 70 | - | - | 22.6% | 4.9% | 71.2% | 12.8% | 9.4% | 1.7% | 5.9% | 124.0x | $72.1B | VS | |
$EFXT Enerflex Ltd. | 74 | 80 | 91 | 83 | - | - | 3.0% | 1.1% | 20.9% | 7.3% | 1.3% | 3.0% | 0.9% | 67.0x | $1.2B | VS | |
$BUD Anheuser-Busch InBev SA/NV | 74 | 84 | 97 | 63 | - | - | 8.2% | 3.5% | 55.3% | 25.9% | 12.4% | 0.7% | 1.7% | 0.0x | $87.0B | VS | |
$SYK STRYKER CORP | 58 | 59 | 56 | 42 | 45.0x | 34.9x | 14.4% | 6.8% | 63.8% | 17.8% | 13.8% | 11.7% | 0.9% | 113.0x | $141.3B | ||
| SECTOR BENCH | - | - | - | - | - | 22.3x | 11.5x | -2.5% | -0.1% | 42.5% | 1.3% | -0.2% | 5.9% | 0.0% | 0.2x | - | REF |
STRYKER CORP (SYK) receives a "Hold" rating with a composite score of 57.9/100. It ranks #909 out of 7,333 stocks in our coverage universe and carries a 3-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
YOY expansion rate
Core pricing power
Operating efficiency
Bottom-line conversion
Equity capital efficiency
Asset base utilization
Financial leverage load
Direct cash return
Kevin A. Lobo
Chief Executive Officer
Labor Force
51,000
59
31
92
Audit Verdict: Average governance indicators based on financial metrics.
No recent insider transactions available for SYK
In-line with peers — no strong momentum signal
Fair valuation relative to peers
Average quality profile
Low volatility — smoother ride and historically better risk-adjusted returns
Aggressive spending — empire-building risk, dilutive growth
Mid-range overall rating
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Manufacturing sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
Projection based on user-defined inputs. Re-calculated daily against current market data.
Reverse DCF Framework — Mauboussin Methodology
Institutional-grade Reverse DCF analysis. This model identifies the growth hurdles embedded in current market prices. When implied growth is significantly lower than historical or projected rates, a margin of safety may exist. Re-audited daily.
No analyst ratings for SYK.
View All RatingsMaterial decline in asset turnover efficiency detected
| Factor | Global | Sector | Tilt |
|---|---|---|---|
| PROFITABILITY | 59 | 55 | +4NEUTRAL |
| MOMENTUM | 42 | 24 | +18ALPHA |
| VALUATION | 56 | 37 | +19ALPHA |
| INVESTMENT | 31 | 38 | -7DRAG |
| STABILITY | 92 | 96 | -4NEUTRAL |
| SHORT INT | 75 | 86 | -11DRAG |
Global = full universe. Sector = relative to industry peers. Positive tilt indicates idiosyncratic strength.
ROIC 27.1% vs WACC 9.1% (spread +18.0%)
GM 64% vs sector 43%, OM 18% vs sector 1%
Capital turnover 1.88x, R&D intensity 6.5%
Rev growth 12%, 10yr history
Interest coverage N/A, Net debt/EBITDA 2.7x
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
Our model assigns STRYKER CORP a Hold rating, with a composite score of 57.9/100 and 3 out of 5 stars. Ranked #909 of 7,333 stocks, SYK presents a mixed quantitative picture — neither compelling enough to initiate new positions nor weak enough to warrant selling. Investors already holding may consider maintaining their position while monitoring for changes in the factor profile.
With a quality score of 59/100, SYK shows adequate but unremarkable business quality. The company reports a return on equity of 14.4% (sector avg: -2.5%), gross margins of 63.8% (sector avg: 42.5%), net margins of 13.8% (sector avg: -0.2%). This suggests the company generates acceptable returns but may lack the competitive positioning or operational efficiency to stand out from peers.
SYK's value score of 56/100 indicates the stock is fairly valued based on its current fundamentals. Key valuation metrics include a P/E ratio of 45.04x, an EV/EBITDA of 34.89x, a P/B ratio of 6.49x. At this level, neither a clear bargain nor overpriced, the stock's attractiveness depends more on forward growth expectations and qualitative factors.
STRYKER CORP's investment score of 31/100 suggests limited reinvestment activity. Key growth metrics include revenue growth of 11.7% vs. a sector average of 5.9% and a return on assets of 6.8% (sector: -0.1%). While this can be positive for mature, cash-generative businesses returning capital to shareholders, it may also signal a lack of growth opportunities or management conservatism.
SYK is currently showing below-average momentum at 42/100, which may indicate weakening institutional interest or negative sentiment shifts. Revenue growth stands at 11.7% year-over-year, while a beta of 0.67 reflects its sensitivity to broader market moves. Investors should note that declining momentum can precede further price weakness, though contrarian opportunities sometimes emerge at these levels.
STRYKER CORP earns an excellent stability score of 92/100, reflecting low price volatility and a conservatively managed balance sheet. Key stability metrics include a beta of 0.67 and a debt-to-equity ratio of 113.00x (sector avg: 0.2x). Stocks with this level of stability tend to act as portfolio anchors, providing downside protection during market corrections while still participating in broad market advances.
SYK carries a short interest score of 75/100, indicating moderate short selling activity. This is a neutral reading — not enough to signal systemic bearishness, but worth monitoring. Specific risk factors include elevated leverage (D/E: 113.00x). At $141.3B market cap (large-cap), STRYKER CORP offers reasonable institutional liquidity.
SYK offers a modest dividend yield of 0.9%. While the income contribution is relatively small, even a small dividend signals management's commitment to shareholder returns and can serve as a signal of financial discipline.
STRYKER CORP is a large-cap company in the Manufacturing sector, ranked #0 of 50 in its sector (100th percentile) and #909 of 7,333 overall (88th percentile). Key comparisons include ROE of 14.4% exceeding the -2.5% sector median and operating margins of 17.8% above the 1.3% sector average. This top-quartile standing reflects exceptional competitive strength relative to Manufacturing peers.
While SYK currently exhibits a HOLD profile, superior opportunities exist within the MANUFACTURING sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.
View Top Manufacturing Alpha →Quant Factor Profile
Key factor gap
Stability (92) vs Investment (31) — closing this gap could shift the rating.
EV/EBITDA 204% ABOVE SECTOR MEDIAN
ROE 681% BELOW SECTOR MEDIAN
Gross Margin 50% ABOVE SECTOR MEDIAN (FAVORABLE)
AUDIT DATA AS OF SEP 30, 2025 (Q2 FY2025)
We rate STRYKER CORP (SYK) as a Hold with a composite score of 57.9/100 at a current price of $380.79. The stock presents a mixed quantitative picture — neither compelling enough to warrant new accumulation nor weak enough to justify selling for existing holders. Our factors are split, and the overall profile suggests patience is warranted.
The rating is primarily driven by strength in stability (92th percentile) and quality (59th percentile), which together account for the majority of the composite score. Offsetting weakness in investment (31th percentile) and momentum (42th percentile) tempers our overall conviction. We assign a Narrow Moat rating (60/100), Medium uncertainty, and Poor capital allocation.
Key items to watch: balance sheet deleveraging progress. Any material change in these dynamics could warrant a reassessment of our rating. The moat trend is stable, which suggests the competitive landscape is stable for now.
STRYKER CORP holds a top-quartile position (#0 of 50) within the Manufacturing sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 57.9/100 places it at rank #909 in our full 7,333-stock universe. With a $141.3B market capitalization, STRYKER CORP operates at meaningful scale within the Manufacturing sector, providing competitive advantages in distribution, procurement, and customer reach.
Revenue is growing at 12%, though momentum at the 42th percentile suggests the market has not yet fully recognized this trajectory. This potential disconnect between fundamental improvement and market recognition could represent an opportunity for patient investors if the growth trend persists.
The margin cascade tells an important story: gross margins of 64% (+21.3pp vs sector) narrow to operating margins of 18% (+16.5pp vs sector) and net margins of 13.8%, yielding a gross-to-net conversion rate of 22%. This conversion rate is typical for the sector, suggesting a standard cost structure without notable efficiency advantages or disadvantages.
At a current price of $380.79, STRYKER CORP is trading near fair value based on current fundamentals. Our value factor score of 56/100 reflects a composite assessment across multiple valuation metrics including price-to-earnings, price-to-book, EV/EBITDA, and price-to-sales ratios relative to both sector peers and the broader market. Valuation metrics are mixed, with no strong signal of mispricing in either direction.
The stock currently trades at a P/E of 45.0x (a 102% premium to the sector median of 22.3x), EV/EBITDA of 34.9x (at a premium), P/B of 6.5x, P/S of 6.2x. The above-sector P/E multiple suggests the market is pricing in superior growth or quality, which our analysis finds only partially justified by current fundamentals.
Gross margins of 64% signal strong pricing power and brand/IP advantages — businesses with margins above 40% have historically demonstrated more resilient earnings through economic cycles.
Revenue growth of 12% confirms the business is expanding its addressable market — growth at this level typically supports multiple expansion and attracts institutional capital.
A P/E of 45.0x leaves little room for execution misses — any earnings disappointment could trigger a sharp multiple compression.
Elevated leverage (113% D/E) amplifies downside risk and limits management's financial flexibility in adverse scenarios.
Elevated short interest (75th percentile) indicates that sophisticated market participants are betting against the stock.
We assign a Medium uncertainty rating to STRYKER CORP. The stock presents a balanced risk profile: significant leverage (113% debt-to-equity) and low beta of 0.67 — while defensive, this may indicate limited upside participation in bull markets. While not risk-free, the core business fundamentals are adequate to withstand moderate economic stress, and the range of potential outcomes around our fair value estimate is manageable.
Specific risk factors that inform our assessment include: significant leverage (113% debt-to-equity); low beta of 0.67 — while defensive, this may indicate limited upside participation in bull markets; elevated valuation multiple (P/E 45.0x) that leaves limited margin for error. Each of these factors independently widens the distribution of potential outcomes, and in combination they create a risk profile that demands careful position sizing. The stability factor at the 92th percentile and quality factor at the 59th percentile provide a quantitative summary of the overall risk landscape.
Key risk mitigants include: healthy gross margins of 64% provide a buffer against cost pressures; above-average stability (92th percentile) suggests predictable business dynamics; large-cap scale ($141.3B) provides resilience. These factors partially offset the identified risks and provide downside protection in adverse scenarios. On balance, the risk-reward profile is favorable for long-term investors.
We rate STRYKER CORP's capital allocation as Poor. Key concerns include suboptimal returns on capital. Exemplary capital allocators generate ROE above 20% and maintain conservative leverage — STRYKER CORP significantly underperforms these benchmarks, raising questions about management's ability to create shareholder value.
Investors should scrutinize management's reinvestment decisions and balance sheet trajectory before committing capital. Poor capital allocation often compounds over time: overlevered balance sheets limit strategic flexibility, while low returns on capital destroy shareholder value. We would need to see sustained improvement in profitability metrics and balance sheet discipline before considering an upgrade.
In summary, STRYKER CORP receives a Hold rating with a composite score of 57.9/100 (rank #909 of 7,333). Our quantitative framework assigns a Narrow Moat (60/100, trend: stable), Medium uncertainty, and Poor capital allocation. The average factor score across quality, value, momentum, stability, and investment is 56/100.
Our analysis supports a neutral stance on STRYKER CORP. While the quantitative profile is not weak enough to warrant selling, it lacks the multi-factor strength required for a buy recommendation. Existing holders should maintain positions and monitor for catalysts — either fundamental improvement or valuation compression — that would shift the risk-reward balance.
Analysis derived from Blank Capital Research quantitative terminal. For informational purposes only. No trade solicitation. Past performance not indicative of future results. Consult a qualified advisor.
We assign STRYKER CORP a Narrow Moat rating with a composite moat score of 60/100. The ROIC-WACC spread of +18.0% is the primary signal of economic value creation. The company possesses identifiable competitive advantages, though they are less entrenched than those of wide-moat peers. Our analysis indicates that STRYKER CORP can sustain above-average returns on invested capital for at least 10 years, with the strongest contributor being margin superiority at 18.1/20.
The strongest moat sources are margin superiority (18.1/20) and economic value creation (17.6/20). GM 64% vs sector 43%, OM 18% vs sector 1%. ROIC 27.1% vs WACC 9.1% (spread +18.0%). These pillars form the core of STRYKER CORP's competitive identity and are the primary drivers of excess returns in our framework.
Areas of relative weakness include reinvestment efficiency (5.6/20) and financial resilience (6/20). Capital turnover 1.88x, R&D intensity 6.5%. Improvement in these areas could meaningfully widen the moat over time, while deterioration would be an early warning of competitive erosion.
Our moat trend assessment is Stable. Multi-year ROIC and operating margin trajectories show neither meaningful improvement nor deterioration, suggesting the competitive position is steady. We expect STRYKER CORP's moat profile to remain largely unchanged absent a material shift in return on capital or industry dynamics.
Key profit drivers include gross margins of 64% providing a solid profitability foundation, operating margins of 18% reflecting effective cost management, moderate revenue growth of 12%. The margin cascade from 64% gross to 18% operating to 13.8% net reveals the company's cost structure and reinvestment intensity. Our analysis indicates that profit quality is adequate though not exceptional, with the quality factor at the 59th percentile.
The margin profile shows gross margins of 64%, operating margins of 18%, net margins of 13.8%. Return metrics include ROE of 14.4% and ROA of 6.8%. Relative to the Manufacturing sector, gross margins are 21.3 percentage points above the sector median of 43%, and ROE of 14.4% compares to a sector median of -2.5%.
The balance sheet reflects above-average leverage with D/E of 113%, a dividend yield of 0.91%, revenue growth of 12%. The sector median D/E is 0%, putting STRYKER CORP at higher leverage than the typical peer. Overall balance sheet health is adequate for the current business environment.
Above 50MA
37.18%
Net New Highs
+51081

Boston Scientific stock plummeted 17.5% on February 4, 2026, despite beating Q4 earnings expectations with 16% sales growth and 14% adjusted EPS growth. The sharp decline was driven by cautious 2026 guidance that fell one penny short of analyst expectations and weaker electrophysiology sales. The analyst argues the market reaction is overdone, citing strong fundamentals including $4.2 billion projected free cash flow for 2026 and 12 consecutive quarters of double-digit sales growth.
Five community organizations selected to receive AED's will be recognized during a special gathering at the hospital.
Global Surgical Equipment Market is poised for significant growth, driven by the increasing demand for advanced surgical instruments, minimally invasive surgery tools, and disposable surgical equipment. According to Maximize Market Research, the market size was valued at USD 14.16 Billion in 2025 and is projected to reach nearly USD 27.40 Billion by 2032, registering a CAGR of 8.6% from 2025 to 2032.
Intuitive Surgical, Edwards and Electromed tap GenAI tailwinds as AI healthcare spending surges, despite industry under performance.
Stryker (NYSE:SYK), a global leader in medical technologies, announced the launch of Synchfix™ EVT, its next-generation flexible syndesmotic fixation device designed to simplify surgical deployment while supporting ankle stabilization in patients with syndesmotic disruptions.